Cargando…

Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model

PURPOSE: Extracellular Vesicles (EVs) are a heterogeneous group of cell-derived membranous nanoparticles involved in several physiopathological processes. EVs play a crucial role in the definition of the extracellular microenvironment through the transfer of their cargo. Psoriasis is a prototypical...

Descripción completa

Detalles Bibliográficos
Autores principales: Capriotti, Lorena, Iuliano, Marco, Lande, Roberto, Frasca, Loredana, Falchi, Mario, Rosa, Paolo, Mangino, Giorgio, Romeo, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488619/
https://www.ncbi.nlm.nih.gov/pubmed/36147689
http://dx.doi.org/10.2147/JIR.S373150
_version_ 1784792698595573760
author Capriotti, Lorena
Iuliano, Marco
Lande, Roberto
Frasca, Loredana
Falchi, Mario
Rosa, Paolo
Mangino, Giorgio
Romeo, Giovanna
author_facet Capriotti, Lorena
Iuliano, Marco
Lande, Roberto
Frasca, Loredana
Falchi, Mario
Rosa, Paolo
Mangino, Giorgio
Romeo, Giovanna
author_sort Capriotti, Lorena
collection PubMed
description PURPOSE: Extracellular Vesicles (EVs) are a heterogeneous group of cell-derived membranous nanoparticles involved in several physiopathological processes. EVs play a crucial role in the definition of the extracellular microenvironment through the transfer of their cargo. Psoriasis is a prototypical chronic inflammatory disease characterized by several secreted mediators, among which antimicrobial peptides (AMPs) are considered pivotal in the development of the psoriatic inflammatory microenvironment. The role of EVs in the pathogenesis of psoriasis has not been elucidated yet, even if emerging evidence demonstrated that interleukin-17A (IL-17A), the psoriasis-related principal cytokine, modifies EVs release and cargo content. The aim of this work was to analyze whether, besides IL-17A, other psoriasis-related cytokines (ie, IFN-γ, TNF-α, IL-22 and IL-23) could affect EVs release and their AMPs mRNAs cargo as well as to analyze the potential biological effect due to EVs internalization by different acceptor cells. METHODS: Nanoparticle tracking analysis (NTA) was performed on supernatants of HaCaT cells stimulated with IL-17A, IFN-γ, TNF-α, IL-22 or IL-23 to enumerate EVs. Real-Time RT-PCR was used for gene expression analysis in cells and EVs. Confocal microscopy and Flow cytometry were used to, respectively, study Netosis and EVs internalization. RESULTS: IL-17A and IFN-γ increased EVs release by HaCaT cells. All the tested cytokines modulated AMPs mRNA expression in parental cells and in their respective EVs. S100A12 and hBD2 mRNAs were upregulated following IL-17A and IL-22 treatments. Interestingly, EVs derived from cytokine treated HaCaT cells induced Netosis in freshly isolated neutrophils. Upregulation of S100A12 and hBD2 mRNA was also detectable in acceptor cells incubated with EVs derived from cells treated with psoriasis-related cytokines. CONCLUSION: The obtained results highlighted the role of EVs in the composition of psoriasis-associated secretome and microenvironment also suggesting the EV involvement in the spreading of the disease mediators and in the possible associated comorbidities.
format Online
Article
Text
id pubmed-9488619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94886192022-09-21 Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model Capriotti, Lorena Iuliano, Marco Lande, Roberto Frasca, Loredana Falchi, Mario Rosa, Paolo Mangino, Giorgio Romeo, Giovanna J Inflamm Res Original Research PURPOSE: Extracellular Vesicles (EVs) are a heterogeneous group of cell-derived membranous nanoparticles involved in several physiopathological processes. EVs play a crucial role in the definition of the extracellular microenvironment through the transfer of their cargo. Psoriasis is a prototypical chronic inflammatory disease characterized by several secreted mediators, among which antimicrobial peptides (AMPs) are considered pivotal in the development of the psoriatic inflammatory microenvironment. The role of EVs in the pathogenesis of psoriasis has not been elucidated yet, even if emerging evidence demonstrated that interleukin-17A (IL-17A), the psoriasis-related principal cytokine, modifies EVs release and cargo content. The aim of this work was to analyze whether, besides IL-17A, other psoriasis-related cytokines (ie, IFN-γ, TNF-α, IL-22 and IL-23) could affect EVs release and their AMPs mRNAs cargo as well as to analyze the potential biological effect due to EVs internalization by different acceptor cells. METHODS: Nanoparticle tracking analysis (NTA) was performed on supernatants of HaCaT cells stimulated with IL-17A, IFN-γ, TNF-α, IL-22 or IL-23 to enumerate EVs. Real-Time RT-PCR was used for gene expression analysis in cells and EVs. Confocal microscopy and Flow cytometry were used to, respectively, study Netosis and EVs internalization. RESULTS: IL-17A and IFN-γ increased EVs release by HaCaT cells. All the tested cytokines modulated AMPs mRNA expression in parental cells and in their respective EVs. S100A12 and hBD2 mRNAs were upregulated following IL-17A and IL-22 treatments. Interestingly, EVs derived from cytokine treated HaCaT cells induced Netosis in freshly isolated neutrophils. Upregulation of S100A12 and hBD2 mRNA was also detectable in acceptor cells incubated with EVs derived from cells treated with psoriasis-related cytokines. CONCLUSION: The obtained results highlighted the role of EVs in the composition of psoriasis-associated secretome and microenvironment also suggesting the EV involvement in the spreading of the disease mediators and in the possible associated comorbidities. Dove 2022-09-16 /pmc/articles/PMC9488619/ /pubmed/36147689 http://dx.doi.org/10.2147/JIR.S373150 Text en © 2022 Capriotti et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Capriotti, Lorena
Iuliano, Marco
Lande, Roberto
Frasca, Loredana
Falchi, Mario
Rosa, Paolo
Mangino, Giorgio
Romeo, Giovanna
Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model
title Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model
title_full Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model
title_fullStr Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model
title_full_unstemmed Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model
title_short Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model
title_sort potential pathogenetic role of antimicrobial peptides carried by extracellular vesicles in an in vitro psoriatic model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488619/
https://www.ncbi.nlm.nih.gov/pubmed/36147689
http://dx.doi.org/10.2147/JIR.S373150
work_keys_str_mv AT capriottilorena potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT iulianomarco potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT landeroberto potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT frascaloredana potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT falchimario potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT rosapaolo potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT manginogiorgio potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel
AT romeogiovanna potentialpathogeneticroleofantimicrobialpeptidescarriedbyextracellularvesiclesinaninvitropsoriaticmodel